On going investigation against GlaxoSmithKline in connection with its drug, Avandia. Avandia was designed to treat type II diabetes. Avandia, the drug developed, marketed and distributed to treat Type II diabetes mellitus, caused serious side effects, notably cardiovascular problems, including heart attack, heart failure, and primary pulmonary hypertension ("HPP"). Moreover, women taking Avandia may be exposed to a higher risk of bone fracture. On June 14, 2007, the New England Journal of Medicine released a study which found that there was an increased risk of heart attacks by 43%. On November 14, 2007, the Food & Drug Administration required GlaxoSmithKline add a "black box" to the label warning consumers of s cardiovascular risk.
Do not change medications without first consulting your doctor.